Ki-Chul Sung1, Sung-Chul Cha2, Joo-Wook Sung2, Min-Suk So2, Christopher D Byrne3. 1. Division of Cardiology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, #108, Pyung Dong, Jongro-Ku, Seoul 110-746, Republic of Korea. Electronic address: kcmd.sung@samsung.com. 2. Division of Cardiology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, #108, Pyung Dong, Jongro-Ku, Seoul 110-746, Republic of Korea. 3. Nutrition and Metabolism Unit, IDS Building, Southampton General Hospital, University of Southampton, and Southampton National Institute for Health Research Biomedical Research Centre, MP 887 Southampton, UK.
Abstract
BACKGROUNDS AND AIMS: Whether obesity increases risk of cardiovascular disease (CVD) and fatty liver because of the co-existence of other risk factors is uncertain. We investigated odds ratios (ORs) for: a) a measure of pre-clinical atherosclerosis and b) fatty liver, in metabolically healthy obese (MHO) subjects, metabolically abnormal obese (MAO) subjects and metabolically abnormal non obese subjects (MANO), using a metabolically healthy non obese (MHNO) group as the reference. METHODS AND RESULTS: 14,384 South Koreans from an occupational cohort underwent cardiac computed tomography (CT) estimation of CAC score, liver ultrasound determination of fatty liver, and measurement of cardiovascular risk factors. Pre-clinical atherosclerosis was defined by a CAC score >0. We used logistic regression to determine ORs for CAC >0, and fatty liver in MHO, MAO and MANO subjects (reference group MHNO). There was no increase in OR for CAC score >0 (OR = 0.93, [95% CIs 0.67,1.31], p = 0.68), in the MHO group, whereas there was an increase in the ORs for CAC score >0 in the MAO, and MANO groups (OR = 1.64 [95% CI 1.36,1.98], p < 0.001) and (OR = 1.38 [95% CI 1.17,1.64], p < 0.001), respectively. In contrast, for fatty liver, there was an increase in OR in each group (OR = 3.63 [95% CI 3.06, 4.31] p < 0.001); (OR = 5.89 [5.18,6.70] p < 0.001); and (OR = 1.83 [95% CI 1.69,2.08]) in the MHO, MAO group and MANO groups respectively. CONCLUSION: MHO subjects are at risk of fatty liver but attenuated risk of pre-clinical atherosclerosis. Both MAO and MANO subjects are at risk of fatty liver and pre-clinical atherosclerosis.
BACKGROUNDS AND AIMS: Whether obesity increases risk of cardiovascular disease (CVD) and fatty liver because of the co-existence of other risk factors is uncertain. We investigated odds ratios (ORs) for: a) a measure of pre-clinical atherosclerosis and b) fatty liver, in metabolically healthy obese (MHO) subjects, metabolically abnormal obese (MAO) subjects and metabolically abnormal non obese subjects (MANO), using a metabolically healthy non obese (MHNO) group as the reference. METHODS AND RESULTS: 14,384 South Koreans from an occupational cohort underwent cardiac computed tomography (CT) estimation of CAC score, liver ultrasound determination of fatty liver, and measurement of cardiovascular risk factors. Pre-clinical atherosclerosis was defined by a CAC score >0. We used logistic regression to determine ORs for CAC >0, and fatty liver in MHO, MAO and MANO subjects (reference group MHNO). There was no increase in OR for CAC score >0 (OR = 0.93, [95% CIs 0.67,1.31], p = 0.68), in the MHO group, whereas there was an increase in the ORs for CAC score >0 in the MAO, and MANO groups (OR = 1.64 [95% CI 1.36,1.98], p < 0.001) and (OR = 1.38 [95% CI 1.17,1.64], p < 0.001), respectively. In contrast, for fatty liver, there was an increase in OR in each group (OR = 3.63 [95% CI 3.06, 4.31] p < 0.001); (OR = 5.89 [5.18,6.70] p < 0.001); and (OR = 1.83 [95% CI 1.69,2.08]) in the MHO, MAO group and MANO groups respectively. CONCLUSION: MHO subjects are at risk of fatty liver but attenuated risk of pre-clinical atherosclerosis. Both MAO and MANO subjects are at risk of fatty liver and pre-clinical atherosclerosis.
Authors: Jordan E Lake; Xiuhong Li; Frank J Palella; Kristine M Erlandson; Dorothy Wiley; Lawrence Kingsley; Lisa P Jacobson; Todd T Brown Journal: AIDS Date: 2018-01-02 Impact factor: 4.632
Authors: Shasha Yu; Hongmei Yang; Xiaofan Guo; Liqiang Zheng; Yingxian Sun Journal: Int J Environ Res Public Health Date: 2016-05-27 Impact factor: 3.390
Authors: Ruizhi Zheng; Min Yang; Yuqian Bao; Hong Li; Zhongyan Shan; Bo Zhang; Juan Liu; Qinguo Lv; Ou Wu; Yimin Zhu; Maode Lai Journal: Int J Environ Res Public Health Date: 2015-10-28 Impact factor: 3.390
Authors: Luca A Lotta; Ali Abbasi; Stephen J Sharp; Anna-Stina Sahlqvist; Dawn Waterworth; Julia M Brosnan; Robert A Scott; Claudia Langenberg; Nicholas J Wareham Journal: Diabetes Care Date: 2015-11 Impact factor: 19.112